Charting the future of oligonucleotide bioanalysis
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies
Explore the history, evolution, and diverse applications of green fluorescent protein and other fluorescent proteins, from discovery to cutting-edge bioimaging tools
Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows
Cleanroom microbiology expert adds new locking lid plate options to Redipor prepared media range - available from Cherwell and AnalytiChem
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale
Scientists have discovered a molecule that could aid the development of new treatments for MND
Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing
GutID is the first microbiome test able to identify all bacteria in the gut at the strain level and could help manage and prevent a wide range of diseases
Integrating the Compresstome Vibrating Microtome into the Agilent Seahorse XF Flex tissue workflow
Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR
Couldn’t make it to Baltimore? Here’s your essential round-up of the biggest scientific highlights, product debuts, and industry shifts from this year’s mass spectrometry event
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotency
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics
John Kawola, CEO of micro-3D printing company BMF, explores the role of 3D printing in organoid and cancer research
Supported by 50 years of spectroscopy expertise, this subdivision aims to "deliver accuracy, consistency, and insight"
This next-generation in LC-mass detection is setting new standards for intelligent mass detection, sensitivity, and sustainability
Enabling functional proteoform sequencing and post-translational modification (PTM) identification and localization with unprecedented depth and speed
Offering up to 50% improved peptide sensitivity, this technology further enhances robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows
Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class
Rob Walton, CEO of SPT Labtech, shares how a customer-centric approach is shaping the next generation of life science research and inspiring ingenuity
This collaboration aims to expand metabolite and lipid analysis through the power of mass spectrometry
Introducing a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS based proteomics